Accendra Health, Inc. Deferred Foreign Income Tax Expense (Benefit)
Accendra Health, Inc. (ACH) reported Deferred Foreign Income Tax Expense (Benefit) of -$393.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-28.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredForeignIncomeTaxExpenseBenefit · last filed 2025-02-28
- Accendra Health, Inc. deferred foreign income tax expense (benefit) for fiscal 2024 was -$393.00K.
- Accendra Health, Inc. deferred foreign income tax expense (benefit) for fiscal 2023 was -$829.00K.
- Accendra Health, Inc. deferred foreign income tax expense (benefit) for fiscal 2022 was -$12.29M.
- Accendra Health, Inc. deferred foreign income tax expense (benefit) for fiscal 2021 was -$3.52M, a 2000.00% decline from fiscal 2020.
| Period end | Deferred Foreign Income Tax Expense (Benefit) 12 month | Deferred Foreign Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|
| 2024-12-31 | -$393.00K 10-K · filed 2025-02-28 | |
| 2023-12-31 | -$829.00K 10-K · filed 2025-02-28 | |
| 2022-12-31 | -$12.29M 10-K · filed 2025-02-28 | |
| 2021-12-31 | -$3.52M 10-K · filed 2024-02-20 | |
| 2020-12-31 | $185.00K 10-K · filed 2023-02-28 | |
| 2019-12-31 | -$9.68M 10-K · filed 2022-02-23 | |
| 2018-12-31 | -$3.54M 10-K · filed 2020-03-04 | -$3.42M 10-K · filed 2019-03-06 |
| 2017-12-31 | -$5.08M 10-K · filed 2019-03-06 | |
| 2016-12-31 | -$1.97M 10-K · filed 2019-03-06 | |
| 2015-12-31 | -$981.00K 10-K · filed 2018-02-23 | |
| 2014-12-31 | -$3.96M 10-K · filed 2017-02-17 | |
| 2013-12-31 | -$2.14M 10-K · filed 2016-02-25 | |
| 2012-12-31 | -$1.91M 10-K · filed 2015-02-23 | |
| 2011-12-31 | $0.00 10-K · filed 2014-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HENRY SCHEIN INC (HSIC) | United States | $9.536B | 23.59 |